People diagnosed with cancer often say they were stunned when they heard the news and unable to process what they heard afterward, as if a fog had obscured everything. After this initial shock, it is important to learn about what comes next. Leukemia survivor Doug Smith shares his experiences with coping with this fog.
A bone marrow/stem cell transplant is an effective treatment option for several cancers, even when the patient is older. Read how you and your doctor can determine if the treatment is right for you.
After being diagnosed with cancer, journalist Loriana Hernandez-Aldama learned that living a healthy lifestyle before treatment begins can help you cope with and manage the challenges to come. This practice of preparing yourself for cancer treatment is sometimes called prehabilitation.
Read key research highlights that will be presented at the 2018 ASCO Annual Meeting, including monitoring symptoms with technology, screening and genomic testing for lung cancer, and new treatment regimens for breast cancer and T-cell leukemia and lymphoma.
The 2018 Clinical Cancer Advances report of the American Society of Clinical Oncology has crowned an adoptive cell immunotherapy as its Advance of the Year. What is this innovative cancer treatment? What are the risks and benefits?
In this month’s From the Editor’s Desk, Dr. Schapira reflects on the mutual trust and respect that can develop between oncologists and their patients.
This year, President Obama has focused attention on treatments and tools that help doctors tailor medical care for individual patients. Research presented at the 2015 ASCO Annual Meeting shows how targeted therapies can be used to improve the care of people with a number of different types of blood cancer.
Hearing the word cancer is one of people’s biggest fears. In this guest post, Dr. Rick Boulay challenges everything you thought you knew about cancer and shares how he found hope after his wife was diagnosed with leukemia.
Recognizing the dramatic advances in the treatment of chronic lymphocytic leukemia (CLL), ASCO named the approval of four new drugs for this disease in 2014 as its first “Advance of the Year.”